Related Experiment Videos
Assessment of percutaneous transluminal coronary angioplasty with 123IODO-heptadecanoic acid
Insights
123I-iodo-heptadecanoic acid (HDA) myocardial scintigraphy shows perfusion defects in stenosed arteries. While HDA is suitable for myocardial perfusion assessment, its half-life measurement is inadequate for clinical use with planar imaging.
Area of Science:
- Nuclear Medicine
- Cardiology
- Radiopharmacology
Background:
- Myocardial perfusion imaging is crucial for diagnosing coronary artery disease.
- 123I-iodo-heptadecanoic acid (HDA) is a fatty acid analog used to assess myocardial metabolism and perfusion.
- Assessing the accuracy and clinical utility of HDA in conjunction with exercise testing and coronary angiography is important.
Purpose of the Study:
- To evaluate the efficacy of 123I-iodo-heptadecanoic acid (HDA) myocardial scintigraphy in detecting perfusion defects.
- To assess changes in HDA half-life following percutaneous transluminal coronary angioplasty (PTCA).
- To determine the clinical applicability of HDA half-life measurements using planar imaging.
Main Methods:
- Ten patients underwent myocardial scintigraphy with 123I-HDA during maximal exercise.
- Six patients were rescanned post-PTCA.
- All patients had coronary angiography to assess arterial stenosis.
Main Results:
- Visible perfusion defects were observed in 74% of myocardial areas with >75% arterial stenosis.
- Mean HDA half-life in areas distal to severe stenosis (>90%) was longer than normal, but not statistically significant.
- Static images showed some post-PTCA changes, but HDA half-lives did not consistently alter.
Conclusions:
- 123I-HDA is a suitable agent for investigating myocardial perfusion.
- Current planar imaging systems are inadequate for reliable clinical measurement of HDA half-life.
- Further advancements in imaging technology may be needed to fully utilize HDA for quantitative perfusion assessment.
Abstract:
Ten patients underwent myocardial scintigraphy with 123I-iodo-heptadecanoic acid (HDA), which was injected in the last minute of maximal exercise testing. Six of the patients were rescanned following percutaneous transluminal coronary angioplasty. All ten patients underwent full coronary angiography. There were visible perfusion defects on the static images in 74% of the myocardial areas which were supplied by an artery with a stenosis greater than 75%. The mean half life recorded from areas distal to an arterial stenosis of at least 90% (35.69 min +/- 41.25 min), was longer than the expected normal mean (18.85 min +/- 3.35 min). However, the difference was not statistically significant. The static images changed in some patients following angioplasty, however there was no consistent alteration in the half lives. It was concluded that HDA is a suitable agent for investigating myocardial perfusion, but that the half life cannot be measured adequately for clinical purposes with a planar imaging system.